Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12CNJ | ISIN: SE0002756130 | Ticker-Symbol: LS6
Frankfurt
19.04.24
08:10 Uhr
0,001 Euro
-0,002
-64,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CLINICAL LASERTHERMIA SYSTEMS AB Chart 1 Jahr
5-Tage-Chart
CLINICAL LASERTHERMIA SYSTEMS AB 5-Tage-Chart

Aktuelle News zur CLINICAL LASERTHERMIA SYSTEMS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08:39Clinical Laserthermia Systems announces timetable and additional information for the upcoming reverse share split1
12.04.Clinical Laserthermia Systems AB: Bulletin from the Extraordinary General Meeting on Friday 12th of April in Clinical Laserthermia Systems AB2
09.04.Clinical Laserthermia Systems Americas, Inc.: CLS Americas Announces 2nd Order of TRANBERG Focal Laser Ablation Accessories Placed by the National Institutes of Health Clinical Center44LOS ANGELES, April 09, 2024 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, today announced...
► Artikel lesen
28.03.Clinical Laserthermia Systems Americas, Inc.: CLS Americas Announces ROSE Urology will use TRANBERG Laser to Treat Prostate Cancer Patients with Focal Laser Ablation2
11.03.Clinical Laserthermia Systems AB: Notice of Extraordinary General Meeting at Clinical Laserthermia Systems AB1
23.02.Clinical Laserthermia Systems AB publishes Year-end report January - December 20231
14.02.Clinical Laserthermia Systems announces that the date for conversion of interim shares is estimated to February 21, 20241
07.02.Clinical Laserthermia Systems will receive ca SEK 23.5 million in connection with the warrant exercise and underwriting commitments for TO 6 B, corresponding to a subscription rate of 100 percent.-
02.02.Clinical Laserthermia Systems AB: Last day of trading in warrants of series TO 6 B is today February 2, 20241
26.01.Clinical Laserthermia Systems AB: Senior executives and larger owner exercise, pro rata, warrants of series TO 6 B for approximately SEK 0.7 million.1
23.01.Clinical Laserthermia Systems AB: The exercise period for warrants of series TO 6 B begins today1
22.01.Clinical Laserthermia Systems AB: The subscription price for warrants of series TO 6 B has been set at SEK 0.10 per share3
17.01.Clinical Laserthermia Systems' business update: focus on accelerating commercial roll-out and updated sales ambitions2
09.01.Clinical Laserthermia Systems receives SEK 8.1 million order from ClearPoint Neuro2
28.12.23Clinical Laserthermia Systems AB: Correction: Clinical Laserthermia Systems nomination committee appointed1
22.12.23Clinical Laserthermia Systems nomination committee appointed1
05.12.23Clinical Laserthermia Systems AB: First patient treated with TRANBERG Thermal Therapy System in nationwide French study evaluating MRI together with biopsies to detect residual prostate cancer after focal therapy1
28.11.23Clinical Laserthermia Systems Americas, Inc.: CLS Americas Selects Quest International to Provide Aftermarket Service and Logistics Operations for TRANBERG Laser Ablation System1
09.11.23Clinical Laserthermia Systems Announces Agreement with KASRAEIAN Urology to Treat Prostate Cancer Patients with TRANBERG Thermal Therapy System2
07.11.23Clinical Laserthermia Systems Announces Initiation of Prostate Cancer Clinical Study in collaboration with U.S based HALO Diagnostics2
Seite:  Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1